A detailed history of Perceptive Advisors LLC transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 12,594,211 shares of NAUT stock, worth $29.5 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares
12,594,211
Previous 12,594,211 -0.0%
Holding current value
$29.5 Million
Previous $29.5 Million 21.8%
% of portfolio
0.94%
Previous 0.85%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$2.34 - $3.39 $8.15 Million - $11.8 Million
3,483,060 Added 38.23%
12,594,211 $37.7 Million
Q4 2021

Feb 14, 2022

BUY
$4.45 - $6.21 $890,000 - $1.24 Million
200,000 Added 2.24%
9,111,151 $47.2 Million
Q2 2021

Aug 16, 2021

BUY
$9.04 - $14.19 $80.6 Million - $126 Million
8,911,151 New
8,911,151 $90 Million

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $292M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.